drugset / Trial / NCT01841606

The Effect of Ondansetron on Cardiac Output in Elective Cesarean Deliveries

NCT01841606

Phase 2 Completed 57 enrolled University of British Columbia
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Ondansetron is a medication routinely given to mothers having cesarean deliveries to help prevent and treat nausea and vomiting. The investigators are studying the hemodynamic effects of prophylactic ondansetron on parturients undergoing elective cesarean deliveries under spinal anesthesia.

Timeline

Start
2013-03
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg Intravenous

Indications

No indication recorded.